Lihua Q. Yang
6 Shuangyong Road
Nanning, 530021, China
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
SEPTIN7 Deficiency Disrupts Endothelial Integrity and Causes Myxomatous Valve Disease in Juvenile Mice.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: August 27, 2026
Association between gut microbiota characteristics and therapeutic efficacy of multimodal combination therapy in hepatocellular carcinoma with portal vein tumor thrombus: a secondary analysis of a prospective phase II trial.
Journal: Frontiers in immunology
Published: April 25, 2026
SATB2 Mediates H3K9 Delactylation by Recruiting HDAC3 to Repress LCN2 and Inhibit Lung Tumor Growth and Metastasis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 13, 2025
Adebrelimab combined with anlotinib plus hepatic arterial infusion chemotherapy or intravenous chemotherapy for first-line treatment of advanced biliary tract cancer: protocol for a randomized open-label clinical study.
Journal: Journal of gastrointestinal oncology
Published: September 05, 2025
Stereotactic body radiation therapy combined with cadonilimab and lenvatinib in the treatment of hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombus: a prospective, multicenter, single-arm, phase II clinical trial.
Journal: Frontiers in immunology
Published: August 17, 2025
A retrospective cohort study on the efficacy and safety for combination therapy of immunotherapy, targeted agent, and chemotherapy versus immunochemotherapy or chemotherapy alone in the first-line treatment of advanced biliary tract carcinoma.
Journal: Journal of gastrointestinal oncology
Published: January 03, 2023
Erratum: Effect of CELSR3 on the Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells: Erratum.
Journal: Journal of Cancer
Published: March 14, 2022
Efficacy and biomarker exploration of camrelizumab combined with apatinib in the treatment of advanced primary liver cancer: a retrospective study.
Journal: Anti-cancer drugs
Published: July 07, 2021
Clinical significance and biological function of transcriptional repressor GATA binding 1 in gastric cancer: a study based on data mining, RT-qPCR, immunochemistry, and vitro experiment.
Journal: Cell cycle (Georgetown, Tex.)
Published: October 12, 2020
Erratum: MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1.
Journal: International journal of clinical and experimental pathology
Published: February 09, 2020
Effect of CELSR3 on the Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells.
Journal: Journal of Cancer
Published: August 14, 2019
Last Updated: 09/26/2026